Pulse Biosciences (PLSE) Competitors $14.48 -0.68 (-4.49%) Closing price 04/8/2025 04:00 PM EasternExtended Trading$14.48 0.00 (0.00%) As of 08:02 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock PLSE vs. IRTC, SLNO, PRCT, NVST, TMDX, ENOV, LIVN, NVCR, LMAT, and WRBYShould you be buying Pulse Biosciences stock or one of its competitors? The main competitors of Pulse Biosciences include iRhythm Technologies (IRTC), Soleno Therapeutics (SLNO), PROCEPT BioRobotics (PRCT), Envista (NVST), TransMedics Group (TMDX), Enovis (ENOV), LivaNova (LIVN), NovoCure (NVCR), LeMaitre Vascular (LMAT), and Warby Parker (WRBY). These companies are all part of the "medical equipment" industry. Pulse Biosciences vs. iRhythm Technologies Soleno Therapeutics PROCEPT BioRobotics Envista TransMedics Group Enovis LivaNova NovoCure LeMaitre Vascular Warby Parker Pulse Biosciences (NASDAQ:PLSE) and iRhythm Technologies (NASDAQ:IRTC) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, community ranking, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk. Do analysts recommend PLSE or IRTC? iRhythm Technologies has a consensus target price of $119.73, indicating a potential upside of 23.63%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Pulse Biosciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Pulse Biosciences 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00iRhythm Technologies 0 Sell rating(s) 2 Hold rating(s) 9 Buy rating(s) 0 Strong Buy rating(s) 2.82 Is PLSE or IRTC more profitable? Pulse Biosciences has a net margin of 0.00% compared to iRhythm Technologies' net margin of -19.14%. Pulse Biosciences' return on equity of -96.89% beat iRhythm Technologies' return on equity.Company Net Margins Return on Equity Return on Assets Pulse BiosciencesN/A -96.89% -74.83% iRhythm Technologies -19.14%-118.83%-11.34% Does the MarketBeat Community prefer PLSE or IRTC? iRhythm Technologies received 162 more outperform votes than Pulse Biosciences when rated by MarketBeat users. Likewise, 66.07% of users gave iRhythm Technologies an outperform vote while only 63.50% of users gave Pulse Biosciences an outperform vote. CompanyUnderperformOutperformPulse BiosciencesOutperform Votes24763.50% Underperform Votes14236.50% iRhythm TechnologiesOutperform Votes40966.07% Underperform Votes21033.93% Do institutionals and insiders hold more shares of PLSE or IRTC? 76.9% of Pulse Biosciences shares are owned by institutional investors. 71.5% of Pulse Biosciences shares are owned by insiders. Comparatively, 0.7% of iRhythm Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term. Which has stronger valuation and earnings, PLSE or IRTC? Pulse Biosciences has higher earnings, but lower revenue than iRhythm Technologies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPulse Biosciences$700K1,391.61-$42.21MN/AN/AiRhythm Technologies$591.84M5.14-$123.41M-$3.64-26.60 Does the media favor PLSE or IRTC? In the previous week, iRhythm Technologies had 7 more articles in the media than Pulse Biosciences. MarketBeat recorded 7 mentions for iRhythm Technologies and 0 mentions for Pulse Biosciences. iRhythm Technologies' average media sentiment score of 1.41 beat Pulse Biosciences' score of 0.00 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Overall Sentiment Pulse Biosciences Neutral iRhythm Technologies Positive Which has more volatility & risk, PLSE or IRTC? Pulse Biosciences has a beta of 1.87, indicating that its stock price is 87% more volatile than the S&P 500. Comparatively, iRhythm Technologies has a beta of 1.45, indicating that its stock price is 45% more volatile than the S&P 500. SummaryiRhythm Technologies beats Pulse Biosciences on 9 of the 16 factors compared between the two stocks. Remove Ads Get Pulse Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for PLSE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart PLSE vs. The Competition Export to ExcelMetricPulse BiosciencesSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$974.13M$3.88B$5.08B$6.91BDividend YieldN/A44.80%5.34%4.25%P/E RatioN/A26.5021.2517.05Price / Sales1,391.6142.89343.8985.99Price / CashN/A51.0838.1534.64Price / Book17.885.496.013.66Net Income-$42.21M$66.64M$3.19B$247.27M7 Day Performance-13.45%-10.99%-8.94%-9.80%1 Month Performance-16.64%-12.30%-6.88%-12.84%1 Year Performance92.30%3.73%0.43%-10.68% Pulse Biosciences Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)PLSEPulse Biosciences0.7127 of 5 stars$14.48-4.5%N/A+92.6%$974.13M$700,000.000.00140Gap UpIRTCiRhythm Technologies1.1785 of 5 stars$104.68-0.3%$119.73+14.4%-14.3%$3.29B$591.84M-28.761,790Positive NewsSLNOSoleno Therapeutics4.5481 of 5 stars$71.45-0.8%$98.86+38.4%+46.5%$3.28BN/A-21.5230High Trading VolumePRCTPROCEPT BioRobotics2.5233 of 5 stars$58.26-3.0%$94.29+61.8%-1.2%$3.19B$224.50M-29.88430Positive NewsGap DownNVSTEnvista4.613 of 5 stars$17.31+2.0%$20.18+16.6%-27.5%$2.98B$2.51B-2.6712,700Positive NewsGap UpTMDXTransMedics Group2.3727 of 5 stars$67.28-1.9%$122.70+82.4%-24.4%$2.26B$441.54M71.58210Gap UpENOVEnovis2.7833 of 5 stars$38.25+1.3%$58.50+52.9%-50.4%$2.18B$2.11B-17.476,800Gap UpLIVNLivaNova3.8188 of 5 stars$39.28+0.4%$61.17+55.7%-38.1%$2.13B$1.25B93.522,900Positive NewsGap UpNVCRNovoCure3.3504 of 5 stars$17.82-5.5%$35.80+100.9%+8.4%$1.96B$605.22M-12.731,320Analyst DowngradeGap DownLMATLeMaitre Vascular2.7451 of 5 stars$83.90+1.0%$95.25+13.5%+19.5%$1.89B$219.86M45.85490Gap UpWRBYWarby Parker3.3714 of 5 stars$18.25-2.3%$23.43+28.4%+5.8%$1.89B$771.32M-67.573,491Positive NewsGap Down Remove Ads Related Companies and Tools Related Companies IRTC Competitors SLNO Competitors PRCT Competitors NVST Competitors TMDX Competitors ENOV Competitors LIVN Competitors NVCR Competitors LMAT Competitors WRBY Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:PLSE) was last updated on 4/9/2025 by MarketBeat.com Staff From Our Partners[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon’s 2025 Silver Crisis (What It Means for You)Silver isn't just a safe haven for your wealth—it's a critical resource in the global tech and energy race. Wi...GoldenCrest Metals | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | SponsoredAll Signs Point To Collapse - 401(k)s/IRAs /Are DoomedRetiring? Not so Fast..Hold Onto Your Bootstraps For A Long Road AheadAmerican Hartford Gold | SponsoredElon’s Silver Play? Trump Clears the PathNothing is confirmed—yet. But Musk has disrupted every industry he's touched, and Trump's policies make the ti...Priority Gold | SponsoredThinking of buying Nvidia? Read this firstI thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pulse Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pulse Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy PLSE Stock Free PLSE Stock Alerts